(Q44115095)

English

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

scientific article published on 26 May 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Ingrid Holst Olsen

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Seppo W Langer

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ida Jepsen

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Maria Assens

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Birgitte Federspiel

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jane Preuss Hasselby

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Carsten Palnaes Hansen

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ulrich Knigge

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

26 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

97-100

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

Carcinoids: the association of histologic growth pattern and survival

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

The management of patients with advanced carcinoid tumors and islet cell carcinomas

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic).

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

Poorly-differentiated endocrine carcinomas of midgut and hindgut origin

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

Chemotherapy and biotherapy in the treatment of neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.582881

21 January 2018

Identifiers

10.3109/0284186X.2011.582881

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44115095&oldid=2106729939"